RGC Stock Summary and Trading Ideas (Regencell Bioscience Holdings Limited - | NASDAQ:RGC)

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.

Regencell Bioscience Holdings Limited - trades on the NASDAQ stock market under the symbol RGC.

As of May 7, 2024, RGC stock price climbed to $5.50 with 1,208 million shares trading.

RGC has a market cap of $71.57 million. This is considered a Micro Cap stock.

RGC has underperformed the market in the last year with a price return of -78.7% while the SPY ETF gained +26.9%. RGC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -30.6% and -14.6%, respectively, while the SPY returned +5.0% and +3.4%, respectively.

RGC support price is $4.50 and resistance is $5.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RGC stock will trade within this expected range on the day.